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Brucellosis is a zoonotic infection mainly affecting farm animals 
such as cattle, sheep and goats. Brucella species primarily infect the 
reproductive tract, causing spontaneous abortions and infertility 
in livestock. Brucellosis has a worldwide distribution, but is most 
prevalent in areas with poorly established domestic animal and public 
health programmes.[1,2] According to the US Centers for Disease 
Control and Prevention, Africa is among the areas most commonly 
affected.
Human brucellosis is thought to be considerably under-diagnosed, 
and although it is a notifiable disease in South Africa (SA), as in many 
parts of the world, it is probably under-reported.[1] Fig. 1 indicates the 
estimated seroprevalence of B. abortus in animals in SA. No formal 
B. melitensis surveillance occurs in SA.
Humans are infected with Brucella by contact with sick animals or 
infected animal products. Organisms can be inoculated via cuts and/
or abrasions when handling infected animal carcasses or products of 
conception, or inhaled as aerosols during these and other procedures. 
Ingestion of unpasteurised milk/dairy products or undercooked meat 
can also lead to infection. High-risk individuals include farmers, 
veterinarians, abattoir workers and meat handlers.[2] Laboratory workers 
are also at risk if inadvertently exposed to live cultures of Brucella.
Most cases of human brucellosis are caused by B. melitensis, which 
is the species associated with more severe disease. The usual animal 
reservoirs for Brucella are sheep and goats (B. melitensis), cattle 
(B. abortus), and pigs (B. suis). Disease in humans may have an acute 
or subacute onset, with the illness having a propensity to become 
chronic and relapsing. Brucellosis is a systemic disease, usually 
presenting as a febrile illness with constitutional symptoms such as 
anorexia, malaise, headaches and chills. The patient may complain of 
arthralgia and back pain, as well as abdominal pain. Clinical findings 
include lymphadenopathy and hepatosplenomegaly. Up to 40% of 
patients with brucellosis have osteoarticular complications. [2] Chronic 
brucellosis is difficult to treat, requiring prolonged antibiotics and in 
some cases surgery.
A definitive diagnosis of Brucella infection is established by 
isolating the organism from blood, bone marrow, cerebrospinal fluid, 
tissue, pus or other relevant samples.[2] A presumptive identification 
of the cultured isolate can be made using basic biochemical tests 
and colonial morphology. Cultured isolates should be referred to a 
specialised facility for further confirmatory testing and speciation, 
which can be done using molecular methods such as the Brucella-
specific, Bruce-ladder multiplex polymerase chain reaction (PCR) 
and biotyping.[1,3,4]
Case report
A 27-year-old man from a town in the Great Karoo, Western 
Cape Province, SA, initially presented to a local district hospital in 
November 2014 with a history of lower back pain and fever with 
new onset of vomiting and diarrhoea. On examination he appeared 
chronically unwell and had abdominal tenderness. Initial blood 
results showed pancytopenia, a normocytic, normochromic anaemia, 
and mildly elevated transaminases and canalicular enzymes. An 
abdominal ultrasound scan revealed diffuse hepatosplenomegaly with 
no granulomas or other focal lesions. One of two blood cultures sent by 
the regional hospital was positive for Gram-negative bacilli after 3 days 
of incubation. This provisional result was communicated to the treating 
clinician, who commenced ceftriaxone empirically. The bone marrow 
report showed prominent serous atrophy and listed common causes for 
this, which included chronic illnesses such as carcinoma, tuberculosis 
and other chronic infections. No granulomas were observed. On 
provisional testing of the cultured isolate, Brucella was suspected 
and the national and provincial departments of health were notified, 
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prompting a veterinary investigation. An 
in-depth history revealed that the patient had 
regularly fed his dog with cattle, sheep and 
goat abattoir waste that was disposed of at an 
open-access municipal waste site in the local 
town. There was no history of consumption of 
unpasteurised milk.
The cultured isolate was subsequently con-
firmed to be B. melitensis by the Department 
of Veterinary Tropical Disease at the Uni-
versity of Pretoria, using Bruce-ladder 
multi plex PCR.[3] Biotyping performed by 
the Agricultural Research Council-Onder-
stepoort Veterinary Institute identified the 
isolate as B. melitensis biovar 1.[4]
Laboratory exposure 
By the time Brucella was suspected as the 
infecting agent, staff at two medical micro-
biology laboratories involved had potentially 
been exposed. Management of staff, which 
included post-exposure prophylaxis, varied 
depending on the risk category.[5] The exposed 
laboratory workers were followed up by 
occupational health and safety staff for 24 weeks.
A total of 75 laboratory staff/visitors were 
identified as having been exposed to the 
organism. To make a serological diagnosis 
of Brucella, paired sera are collected at least 
2 - 4 weeks apart looking for a four-fold or 
greater rise in antibody titre.[6] There are 
numerous commercial kits and serological 
methods commonly used and recommended, 
including the Rose Bengal test, serum 
tube agglutination and enzyme-linked 
immunosorbent assay (ELISA). [2] Serological 
testing using an ELISA, MASTAZYME 
BRUCELLA (MAST Diagnostics, UK), was 
performed for all exposed staff members at 
baseline and then at 6 and 24 weeks.[6]
Five staff members had borderline or low-
level positive IgG or IgM levels detected on 
serological testing at baseline. Repeat testing 
of the same samples as well as repeat samples 
sent 3 - 4 weeks later revealed considerable 
variability, particularly in IgM results.
In the absence of local studies to determine 
appropriate cut-off values in SA, and in view 
of the known intrinsic variability of IgM 
assays as well as known cross-reactivity with 
Enterobacteriaceae, borderline results can be 
difficult to interpret. Failure to demonstrate a 
(four-fold or greater) rise in the titre for specific 
antibody in paired sera usually excludes recent 
infection.[6] None of the staff members tested 
had significant increases in titre (four-fold 
or greater rise in immunoglobulins) over the 
24-week period. All exposed staff members 
remained asymptomatic throughout the 
6-month follow-up period.
Informed consent was obtained from the 
patient, and the study was approved by 
the Human Research Ethics Committee, 
University of Cape Town, SA (HREC REF: 
220/2015).
Veterinary investigation
The state veterinarian’s investigation 
revealed that two other people who had 
lambed goats on a nearby farm in 2014 had 
become ill and were subsequently diagnosed 
with brucellosis, based on serological testing. 
The state veterinarian placed the farm 
under quarantine and initiated sampling 
of the cattle, sheep and goats. Animals 
on surrounding farms were also sampled. 
Serological testing using either the Rose 
Bengal test or the complement fixation 
test was performed. These methods detect 
nonspecific antibodies to both B. melitensis 
and B. abortus.
Of the 100 goats sampled on the farm 
in question, 44 tested positive for Brucella 
on serological testing. All animals on the 
farm were quarantined, but none had been 
sacrificed at the time of writing and no 
samples were available for culture and 
confirmation of the Brucella species. As 
goats do not contract B. abortus, it was 
concluded that the most likely strain causing 
the outbreak was B. melitensis. No animals 
on other surrounding farms had tested 
positive for Brucella at the time of writing.
Discussion
The Department of Agriculture, Forestry and 
Fisheries relies on notifications of diseases 
and important epidemiological incidents 
from veterinarians. The first documented 
cases of veterinary B. melitensis in SA were 
in sheep in 1965 in the Transvaal Province.[7] 
Vaccination is the foundation of a functional 
Brucella control programme in livestock. 
This involves the B. abortus strain 19 (S19) 
and B. abortus RB51 vaccines for cattle and 
B. melitensis Rev. 1 vaccine for sheep and 
goats. These are both live attenuated vaccines 
with the potential of being pathogenic to 
humans if not administered appropriately. [1,8] 
Vaccination regulations in SA as stipulated 
by the Animal Diseases Act 35 of 1984 
have specific guidelines on vaccination of 
animals against Brucella. There are currently 
no safe, efficacious vaccines recommended 
for routine use in prevention of brucellosis 
in at-risk humans. Prevention strategies 
therefore require robust animal programmes 
and adherence to prevention/eradication 
and control protocols.[1] From a public health 
perspective, the key targets would be the 
prevention of infection due to direct/indirect 
contact with infected livestock or live vaccines 
and prevention of food-borne illness, as 
well as strengthening the diagnosis and 
management of human cases with increased 
awareness and safe laboratory practices 
when Brucella species are suspected. From a 
veterinary perspective, occupational hygiene 
involves safe injection practices for animals, 
monitoring and surveillance of disease in 
livestock, and having adequate protocols in 
place to manage an outbreak effectively. The 
prevention of food-borne illness includes 
community education campaigns around 
the consumption of unpasteurised dairy 
products or undercooked meat.
Patients with brucellosis often present 
with nonspecific signs and symptoms. 
Symptoms may persist for weeks to months. 
In the context of a country with a high 
Fig. 1. Map of SA indicating outbreaks of Brucella abortus in animals, 2010 - 2014 (courtesy of the 
Department of Agriculture, Forestry and Fisheries, SA).
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prevalence of tuberculosis and HIV infection, patients presenting 
with features of chronic brucellosis may be misdiagnosed and 
mistreated. As outbreaks of B. melitensis in animals in SA are 
generally infrequent[9] and human cases are even less common, 
there is a lack of awareness among clinicians and laboratory staff, 
who have limited experience in diagnosing and handling this 
organism, with subsequent delay in diagnosis. A high index of 
suspicion and a proper social and exposure history are therefore 
essential in making a timely diagnosis. Effective communication 
between the clinician and the laboratory regarding suspected 
infections is imperative to ensure that all biological samples are 
handled appropriately. The testing laboratory should have protocols 
in place to ensure staff safety and maintain good safety practices. 
When working with a World Health Organization biosafety risk 
level 3 organism such as Brucella, all work should also be performed 
in an appropriate biosafety cabinet, in a biosafety level 3 facility, by 
individuals trained for this work.[10]
Conclusion
A multidisciplinary Brucella control programme can be effective in 
preventing human infections with an approach that integrates three 
key elements: veterinary service, public health, and the medical 
healthcare system.
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